Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.39 |
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | CA9 | Q16790 | 8/20 | 0.39 |
| ▸ | CA12 | O43570 | 7/20 | 0.39 |
| ▸ | CA7 | P43166 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.37 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 3/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19874475 | 0.89 | CA12 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL19874527 | 0.89 | CA12 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL14805173 | 0.82 | CA1 (0.35) | CA1CA2CA9CA12CA7 | |
| SCHEMBL14805176 | 0.82 | CA12 (0.54) | CA1CA2CA9CA12CA7 | |
| SCHEMBL19891667 | 0.81 | CA1 (0.38) | CA1CA2CA9CA12CA7 | |
| SCHEMBL14798633 | 0.81 | CA12 (0.38) | CA1CA2CA9CA12CA7 | |
| SCHEMBL14798639 | 0.81 | CA12 (0.38) | CA1CA2CA9CA12CA7 | |
| SCHEMBL26812 | 0.79 | HTT (0.47) | CA1CA2CA9TSHRMAPK1 | |
| SCHEMBL14798078 | 0.79 | CA1 (0.39) | CA1CA2CA9CA12CA7 | |
| SCHEMBL14797996 | 0.79 | CA12 (0.36) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK (DE) | 2018-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | ARSA, MSRB3, NES | CA1 2828/4885CA2 1444/4885CA9 1954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.